Related Experiment Video
Updated: Aug 18, 2026

Orthotopic Small Bowel Transplantation in Rats
Published on: November 6, 2012
Sclerosing peritonitis after intestinal transplantation in children
Camila Macedo1, Rakesh Sindhi, George V Mazariegos
1Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, USA.
Insights
Sclerosing peritonitis (SP) after intestinal transplantation (ITx) in children can lead to graft failure. Surgical resection offers palliation for this complication, though long-term survival remains a concern.
Area of Science:
- Pediatric Surgery
- Transplantation Immunology
- Gastroenterology
Background:
- Long-term graft dysfunction and loss are significant concerns following intestinal transplantation (ITx).
- Sclerosing peritonitis (SP) is a manifestation of chronic allograft failure, potentially co-occurring with obliterative arteriopathy (OA).
Purpose of the Study:
- To describe the clinical presentation and management of sclerosing peritonitis (SP) in children after intestinal transplantation (ITx).
Main Methods:
- Retrospective review of 121 pediatric ITx cases performed between 1990 and 2003.
- Analysis of clinical presentation, operative findings, and treatment outcomes for three patients who developed SP.
Main Results:
- Three children (2.4%) developed SP at a mean of 6.6 years post-ITx.
- Patients presented with bowel obstruction; operative findings included fibrosis, strictures, and adhesions.
- All patients underwent segmental resection and lysis of adhesions, with initial recovery but limited long-term survival.
Conclusions:
- Sclerosing peritonitis (SP) may represent a distinct form of long-term intestinal allograft degeneration.
- Surgical intervention appears to provide palliative benefits for SP following pediatric ITx.
Abstract:
Long-term graft dysfunction and/or graft loss after intestinal transplantation (ITx) is a significant concern. Sclerosing peritonitis (SP) is a manifestation of chronic allograft failure and its presence may also include classic arterial obliterative arteriopathy (OA) as in chronic rejection. We describe the clinical presentation and management of SP occurring after ITx in children. Case records of 121 children undergoing ITx from 1990 to 2003 were reviewed. Three children (2.4%) presented with SP of the intestine allograft at a mean time of 6.6 yr following ITx as follows: age at Tx (yr) 8.2, and 3.7, with indication for ITx being gastroschisis in two and midgut volvulus in one patient. Type of ITx was isolated intestine in one and liver/intestine in two patients. Gross findings of SP included fibrosis/strictures; microscopically SP showed fibrosis/serositis, and fibrous adhesions; one patient had evidence of chronic allograft vasculopathy. All patients presented with clinical signs and symptoms of bowel obstruction and gastrointestinal contrast studies confirmed distal ileal obstruction (DIO). Operative findings confirmed SP and DIO in all patients; all patients were initially treated with distal segmental intestine allograft resection and lysis of the fibrous peel. All three patients recovered, although two required repeat laparotomy, there is only one long-term survival. SP after ITx may be a different manifestation of long-term intestine allograft degeneration. Surgical resection appears to offer palliation.
Related Concept Videos
Renewal of Intestinal Stem Cells
Kidney Transplant II: Surgical Procedure
Intestinal Obstruction II: Pathophysiology

